Vol 9, No 6 (December 01, 2018): Journal of Gastrointestinal Oncology (Management of Pancreatic Cancer)

Original Article (Management of Pancreatic Cancer)1

Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer
Brandon R. Mancini, Stacey Stein, Shane Lloyd, Charles E. Rutter, Edward James, Bryan W. Chang, Jill Lacy, Kimberly L. Johung
Daily breathing inconsistency in pancreas SBRT: a 4DCT study
Vikren Sarkar, Shane Lloyd, Adam Paxton, Long Huang, Fan-Chi Su, Randa Tao, Jonathan Tward, Hui Zhao, Bill Salter

Review Article (Management of Pancreatic Cancer)1

Large database utilization in health outcomes research in pancreatic cancer: an update
Anna Torgeson, Randa Tao, Ignacio Garrido-Laguna, Benjamin Willen, Amy Dursteler, Shane Lloyd
The role of lineage specifiers in pancreatic ductal adenocarcinoma
Soledad A. Camolotto, Veronika K. Belova, Eric L. Snyder
Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle
Snehal Gajiwala, Anna Torgeson, Ignacio Garrido-Laguna, Conan Kinsey, Shane Lloyd
Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma
Adriana Blakaj, Stacey M. Stein, Sajid A. Khan, Kimberly L. Johung
Advances in surgery for pancreatic cancer
Alexandra W. Acher, Josh Bleicher, Austin Cannon, Courtney Scaife
Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy
Randa Tao, Bryan Ager, Shane Lloyd, Anna Torgeson, Michelle Denney, David Gaffney, Jordan Kharofa, Steven H. Lin, Albert C. Koong, Yoshimi Anzai, John M. Hoffman

Original Article

Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
Thomas T. DeLeon, Marcela A. Salomao, Bashar A. Aqel, Mohamad B. Sonbol, Raquel T. Yokoda, Ahmad H. Ali, Adyr A. Moss, Amit K. Mathur, David M. Chascsa, Jorge Rakela, Alan H. Bryce, Mitesh J. Borad
A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin
Kabir Mody, Samuel O. Antwi, David O. Hodge, Sikander Ailawadhi, Lewis Roberts, Tanios Bekaii-Saab
Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center
Sarah Walcott-Sapp, Scott Naugler, Jeong Youn Lim, Jesse Wagner, Susan L. Orloff, Khashayar Farsad, Kenneth J. Kolbeck, John Kaufman, Erin Maynard, C. Kristian Enestvedt, Skye C. Mayo, Kevin G. Billingsley
External validation of the 8th American Joint Committee on Cancer staging system for gall bladder carcinoma
Hani Oweira, Arianeb Mehrabi, Anwar Giryes, Aysun Tekbas, Omar Abdel-Rahman
Stage II–III colon cancer: a comparison of survival calculators
Riccardo Lemini, Kristopher Attwood, Stacey Pecenka, Juliet Grego, Aaron C. Spaulding, Steven Nurkin, Dorin T. Colibaseanu, Emmanuel Gabriel
Correlation between vascular endothelial growth factor-A expression and tumor location and invasion in patients with colorectal cancer
Susanna Hilda Hutajulu, Dewi Kartikawati Paramita, Joyo Santoso, Muhammad Ivan Aulia Sani, Aghnia Amalia, Gatri Wulandari, Ahmad Ghozali, Johan Kurnianda
Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis
Stephen J. Ramey, Benjamin J. Rich, Deukwoo Kwon, Eric A. Mellon, Aaron Wolfson, Lorraine Portelance, Raphael Yechieli
Survey results of US radiation oncology providers’ contextual engagement of watch-and-wait beliefs after a complete clinical response to chemoradiation in patients with local rectal cancer
Jehan Yahya, Daniel Herzig, Matthew Farrell, Catherine Degnin, Yiyi Chen, John Holland, Simon Brown, Christina Binder, Jerry Jaboin, Vassiliki Liana Tsikitis, Nima Nabavizadeh, Charles R. Thomas Jr, Timur Mitin
The relationship between aspirin use and mortality in colorectal cancer
Heidar J. Albandar, Ronald Markert, Sangeeta Agrawal
A Simplified Peritoneal Sarcomatosis Score for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Samer A. Naffouje, Kiara A. Tulla, George I. Salti
Prognostic importance of lymph node ratio after resection of ampullary carcinomas
Leonardo S. Lino-Silva, Miguel A. Gómez-Álvarez, Rosa A. Salcedo-Hernández, Alejandro E. Padilla-Rosciano, Horacio N. López-Basave
Circulating miRNAs in patients with Barrett’s esophagus, highgrade dysplasia and esophageal adenocarcinoma
Kirill Pavlov, Joost Kluiver, Coby Meijer, Wytske Boersma-van Ek, Frank A. E. Kruyt, Arend Karrenbeld, Jan H. Kleibeuker, Frans T. M. Peters, Anke van den Berg
Exploring the differences between early-onset gastric cancer and traditional-onset gastric cancer
Anwar Giryes, Hani Oweira, Meinrad Mannhart, Michael Decker, Omar Abdel-Rahman
Krukenberg tumours from gastrointestinal cancers—analysis from a tertiary care centre in India
Srinivasan Muthukrishnan, Obla Lakshmanamoorthy Naganathbabu, Satish Devakumar Murugesan, Ulagendra Perumal Srinivasan, Anbalagan Amudhan, Shanmugasundaram Rajendran
How many lymph nodes are enough?—defining the extent of lymph node dissection in stage I–III gastric cancer using the National Cancer Database
Karna Sura, Hong Ye, Charles C. Vu, John M. Robertson, Peyman Kabolizadeh
Supplementation with omega fatty acids increases the mRNA expression level of PLA2G4A in patients with gastric cancer
Donya Bazhan, Mahmoud Shekari Khaniani
Expression of miR-520c in intestinal type gastric adenocarcinoma
Arash Azimzadeh-Isfanjani, Reza Safaralizadeh, Mohamadali Hosseinpour-Feizi, Behrouz Shokouhi, Masuomeh Nemati, Seyyed-Yaghoub Moaddab
Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma
Maha Hasaballah, Raafat Abdel-Malek, Zeinab Zakaria, Mohamad Saeed Marie, Mohammed Sherif Naguib
Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy
Samuel J. Klempner, Munveer S. Bhangoo, Hubert Y. Luu, Seung Tae Kim, Joseph Chao, Kyoung-Mee Kim, Jeeyun Lee

Disclosure:

1. The series “Management of Pancreatic Cancer” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Shane Lloyd served as the unpaid Guest Editor for the series.